Development and external validation of a prognostic model of mortality in Parkinson’s disease
Objective: To develop and validate a prognostic model to predict mortality in Parkinson's disease (PD). Background: Most previous prognostic studies in PD have used unrepresentative…Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders
Objective: Evaluation of the [ 99mTc] - TRODAT- 1 SPECT in the diagnosis of PD and other MD. Create a DATA bank for our population.…Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore
Objective: This study was aimed at assessing caregiver burden (CB) and analyzing its relationship with patient's sociodemographic, motor and non-motor severity as well as health-related…How long is the wait to see a Parkinson’s disease specialist in the United States?
Objective: To investigate the wait time to see a PD specialist in the US. Background: PD patients who see a specialist have better outcomes and…Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease
Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…Transcriptional profile of blood leukocyte in Parkinson’s disease patients after multi-modal exercise and tai chi training
Objective: With next-generation sequencing, we want to get a comprehensive characterization of circulating leukocyte in patients with PD, to interrogate the shared molecular processes perturbed…Familial Parkinson’s disease in the Province of Quebec
Objective: We describe clinical, genealogic and genetic studies in several families with multi-incident Parkinson's disease (PD). Background: PD is a multifactorial trait for which components…A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series
Objective: To describe the incidence and severity of infusion-related adverse events of mesenchymal stem cells (MSC) for Parkinson's disease in patients who underwent treatment. Background:…Cerebellar atrophy in Parkinson’s disease and its implication for network connectivity
Objective: To determine the effect of cerebellar atrophy on resting-state network abnormalities in individuals with Parkinson's disease. Background: In Parkinson's disease, the cerebellum is a…Mitochondrial-nuclear interplay in single respiratory chain-deficient Parkinson’s disease neurons
Objective: To explore the role of the mitochondrial DNA (mtDNA) in the development of respiratory chain complex (CI-IV) deficiencies in the substantia nigra (SN) of…
- « Previous Page
- 1
- …
- 320
- 321
- 322
- 323
- 324
- …
- 388
- Next Page »